Pharmaceutical involvement in phase II breast cancer clinical trials

被引:1
|
作者
Schneider, A.
Zhang, T.
Kamal, A.
Patel, K.
Hamilton, E. P.
Peppercorn, J. M.
机构
[1] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[2] Duke Univ, Med Ctr, Durham, NC USA
关键词
D O I
10.1200/jco.2011.29.15_suppl.6104
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6104
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Clinical Trials and Breast Cancer Disparities
    Bea, Vivian Jolley
    Taiwo, Evelyn
    Balogun, Onyinye D.
    Newman, Lisa A.
    CURRENT BREAST CANCER REPORTS, 2021, 13 (03) : 186 - 196
  • [42] Randomized Clinical Trials in Breast Cancer
    Crago, Aimee M.
    Azu, Michelle
    Tierney, Shannon
    Morrow, Monica
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 19 (01) : 33 - +
  • [43] Genomics in Clinical trials for Breast Cancer
    Enoma, David
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2023, 23 (04) : 325 - 334
  • [44] Clinical Trials and Breast Cancer Disparities
    Vivian Jolley Bea
    Evelyn Taiwo
    Onyinye D. Balogun
    Lisa A. Newman
    Current Breast Cancer Reports, 2021, 13 : 186 - 196
  • [45] CLINICAL TRIALS OF CARDIOTOXICITY IN BREAST CANCER
    Oren, Ohad
    Oren, Michal
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 745 - 745
  • [46] Clinical trials in metastatic breast cancer
    不详
    ONCOLOGY-NEW YORK, 1998, 12 (04): : 527 - +
  • [47] Comparison of binary efficacy endpoints in 11 North Central Cancer Treatment Group phase II metastatic breast cancer clinical trials
    Dueck, A. C.
    Hillman, D. W.
    Liu, H.
    Rowland, K. M.
    Palmieri, F. M.
    Suman, V. J.
    Perez, E. A.
    CANCER RESEARCH, 2009, 69 (02) : 392S - 392S
  • [48] Exclusion of Men from Randomized Phase III Breast Cancer Clinical Trials
    Corrigan, Kelsey L.
    Mainwaring, Walker
    Miller, Austin B.
    Lin, Timothy A.
    Jethanandani, Amit
    Espinoza, Andres F.
    Piotrowski, Matt
    Fuller, C. David
    Stauder, Michael C.
    Shaitelman, Simona F.
    Perkins, George H.
    Woodward, Wendy A.
    Giordano, Sharon H.
    Smith, Benjamin D.
    Ludmir, Ethan B.
    ONCOLOGIST, 2020, 25 (06): : E990 - E992
  • [49] Admissible two-stage designs for phase II cancer clinical trials
    Jung, SH
    Lee, T
    Kim, KM
    George, SL
    CONTROLLED CLINICAL TRIALS, 2003, 24 : 61S - 61S
  • [50] Clinical efficacy of oxaliplatin monotherapy: Phase II trials in advanced colorectal cancer
    Becouarn, Y
    Rougier, P
    SEMINARS IN ONCOLOGY, 1998, 25 (02) : 23 - 31